Martin Brenner sold $1,296 of IBIO
See Remarks at iBio, Inc.. 4,881 shares at an average of $0.27, traded Nov 1, 2023, filed Nov 3, 2023.
Score components
- +15RoleOfficer
- 0Trade size$1k at market
- 0Share of holdings soldSold 2.6% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -48.3%, 3m -81.0%, 6m -65.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-23-114269, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 1, 2023 | SOpen-market sale Common Stock | -4,881 | $0.27 | $1,296 | 182,502 | Nov 3, 2023 |
Related signals
Other insiders at iBio, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 48Moderate | iBio, Inc. | Marc Banjak Chief Legal Officer | $23k 13,934 shares | +126% | |
| 48Moderate | iBio, Inc. | Martin Brenner See Remarks | $25k 12,336 shares | +67% | |
| 62Notable | iBio, Inc. | Felipe Duran Chief Financial Officer | $50k 24,835 shares | +223% | |
| 45Moderate | iBio, Inc. | David Arkowitz director | $50k 18,382 shares | - | |
| 40Moderate | iBio, Inc. | Marc Banjak Chief Legal Officer | $25k 9,191 shares | +490% | |
| 40Moderate | iBio, Inc. | Martin Brenner See Remarks | $25k 9,191 shares | +101% | |
| 38Weak | iBio, Inc. | William D Clark director | $4,999 1,838 shares | - | |
| 47Moderate | iBio, Inc. | Felipe Duran Chief Financial Officer | $25k 9,191 shares | +472% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.